Tuberculosis (TB) notification rates in Africa have doubled since the early 1980s, with the largest rises in countries most affected by the HIV epidemic. HIV increases the risk of TB in those latently infected with M tuberculosis and increases the risk of active disease soon after new infection or re-infection with M tuberculosis. Overall, the risk of TB in those with HIV infection is about four to ten times that in those without HIV infection. The risk starts to rise soon after infection with HIV, and continues to increase with progressive immunosuppression. At a population level, the relative risk for the association of HIV and TB increases as the HIV epidemic progresses, and will continue to increase for some time after a fall in HIV incidence due to the long latent period of HIV. The proportion of TB currently directly attributable to HIV in Africa has been estimated at 31%, but the true impact of HIV on TB will be even greater because of onward transmission from the extra TB cases. Antiretroviral treatment for advanced HIV-disease can decrease the risk of TB, but would have to be used early and extensively to have a large effect at the population level.
Keywords
- Human Immunodeficiency Virus
- Human Immunodeficiency Virus Type
- Acquire Immune Deficiency Syndrome
- Tuberculosis Infection
- Clinical Infectious Disease
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C. & Dye, C. (2003). The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine, 163, 1009–1021
Pape, J., Jean, S. S., Ho, J. L., Hafner, A. & Johnson, W. D. (1999). Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. The Lancet, 342, 268–272
Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., et al. (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine, 320, 545–550
Selwyn, P. A., Sckell, B., Alcabes, P., Friedland, G. H., Klein, R. S. & Schoenbaum, E. E. (1992). High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA, 268, 504–509
Rubinstien, E. M., Madden, G. M. & Lyons, R. W. (1996). Active tuberculosis in HIV-infected injecting drug users from a low-rate tuberculosis area. Journal of Acquired Immune Deficiency Syndromes Human Retrovirology, 11, 448–454
Markowitz, N., Hansen, N. I., Hopewell, P. C., Glassroth, J., Kvale, P. A., Mangura, B. T, et al. (1997). Incidence of tuberculosis in the United States among HIV-infected persons. Annals of Internal Medicine, 126, 123–132
Moreno, S., Baraia-Etxaburu, J., Bouza, E., Parras, F., Perez-Tascon, M., Miralles, P., et al. (1993). Risk for developing tuberculosis among anergic patients infected with HIV. Annals of Internal Medicine, 119, 194–198
Moreno, S., Miralles, P., Diaz, M. D., Baraia, J., Padilla, B., Berenguer, J. & Alberdi, J. C. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long term effect on development of tuberculosis and survival. Archives of Internal Medicine, 157, 1729–1734
Guelar, A., Gatell, J. M., Verdejo, J., Podzamczer, D., Lozano, L., Aznar, E., et al. (1993). A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS, 7, 1345–1349
Antonucci, G., Girardi, E., Raviglione, M. C. & Ippolito, G. (1995). Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA, 274, 143–148
Girardi, E., Antonucci, G., Ippolito, G., Raviglione, M. C., Rapiti, E., Di Perri, G. & Babudieri, S. (1997). Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients. The Gruppo Italiano di Studio Tubercolosi e AIDS. Archives of Internal Medicine, 157, 797–800
Gilks, C. F., Godfrey-Faussett, P., Batchelor, B. I. F., Ojoo, J. C., Ojoo, S. J., Brindle, R. J., et al. (1997). Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya. AIDS, 11, 911–918
Hawken, M. P., Meme, H. K., Elliott, L. C., Chakaya, J. M., Morris, J. S., Githui, W. A., et al. (1997). Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. AIDS, 11, 875–882
Whalen, C. C, Johnson, J. L., Okwera, A., Hom, D. L., Huebner, R. & Mugyenyi, P., et al. (1997). A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. New England Journal of Medicine, 337, 801–808
Johnson, J. L., Okwera, A., Hom, D. L., Mayanja, H., Mutuluuza Kityo, C., Nsubuga, P., et al. (2001). Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS, 15, 2137–2147
Mwinga, A., Hosp, M., Godfrey-Faussett, P., Quigley, M., Mwaba, P., Mugala, B. N., et al. (1998). Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS, 12, 2447–2457
de Pinho, A. M., Santoro-Lopes, G., Harrison, L. H. & Schechter, M. (2001). Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil. AIDS, 15, 2129–2135
Swaminathan, S., Ramachandran, R., Baskaran, G., Paramasivan, C. N., Ramanathan, U., Venkatesan, P., et al. (2000). Risk of development of tuberculosis in HIV-infected patients. International Journal of Tuberculosis and Lung Disease, 4, 839–844
Rieder, H. L. (1995). Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tubercle and Lung Disease, 76, 114–121
Vynnycky, E. & Fine, P. E. M. (1997). The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiology Infection, 119, 183–201
Leroy, V., Msellati, P., Lepage, P., Batungwanayo, J., Hitimana, D. G., Taelman, H., et al. (1995). Four years of natural history of HIV-1 infection in african women: a prospective cohort study in Kigali (Rwanda), 1988–1993. Journal of Acquired Immune Deficiency Syndromes, Human Retrovirology, 9, 415–421
Allen, S., Batungwanayo, J., Kerlikowske, K., Lifson, A. R., Wolf, W., Granich, R., et al. (1992).Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. American Review of Respiratory Diseases, 146, 1439–1444
Braun, M. M., Badi, N., Ryder, R. W., Baende, E., Mukadi, Y., Nsuami, M., et al. (1991). A retrospective cohort study of the risk of TB among women of childbearing age with HIV infection in Zaire. American Review of Respiratory Diseases, 143, 501–504
Ryder, R. W., Batter, V., Kaseka, N., Behets, F., Sequeira, D., M’Boly, E., et al. (2000). Effect of HIV-1 infection on tuberculosis and fertility in a large workforce in Kinshasa, Democratic Republic of the Congo. AIDS Patient Care and STDs, 14, 297–304
Glynn, J. R., Warndorff, D. K., Malema, S. S., Mwinuka, V., Ponnighaus, J. M., Crampin, A. C. & Fine, P. E. (2000). Tuberculosis: associations with HIV and socioeconomic status in rural Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 500–503
Corbett, E. L., Churchyard, G. J., Clayton, T. C., Williams, B. G., Mulder, D., Hayes, R. J. & De Cock, K. M. (2000). HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS, 14, 2759–2768
Corbett, E. L., Churchyard, G. J., Charalambos, S., Samb, B., Moloi, V., Clayton, T. C., et al. (2002). Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clinical Infectious Diseases, 34, 1251–1258
Sonnenberg, P., Glynn, J. R., Fielding, K., Murray, J., Godfrey Fausett, P. & Shearer, S. (2004). HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV. AIDS, 18, 657–662
Morgan, D., Mahe, C., Mayanja, B. & Whitworth, J. A. (2002). Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: Prospective cohort study. BMJ, 324, 193–196
Wolday, D., Hailu, B., Girma, M., Hailu, E., Sanders, E. & Fontanet, A. L. (2003). Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians. International Journal of Tuberculosis and Lung Disease, 7, 110–116
Glynn, J. R. (1998). Resurgence of tuberculosis and the impact of HIV infection. British Medical Bulletin, 54, 579–593
Van den Broek, J., Borgdorff, M. W., Pakker, N. G., Chum, H. J., Klokke, A. H., Senkoro, K. P. & Newell, J. N. (1993). HIV-1 infection as a risk factor for the development of tuberculosis: A case-control study in Tanzania. International Journal of Epidemiology, 22, 1159–1165
Orege, P. A., Fine, P. E. M., Lucas, S. B., Obura, M., Okelo, C., Okuku, P. & Were, M. (1993).A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in Western Kenya. Tubercle and Lung Disease, 74, 377–381
Ponnighaus, J. M., Mwanjasi, L. J., Fine, P. E. M., Shaw, M. A., Turner, A. C., Oxborrow, S. M., et al. (1991). Is HIV infection a risk factor for leprosy? International Journal of Leprology, 59, 221–228
Glynn, J. R., Warndorff, D. K., Fine, P. E. M., Msiska, G. K., Munthali, M. M. & Ponnighaus, J. M. (1997). The impact of HIV on morbidity and mortality from tuberculosis in sub-Saharan Africa: A study in rural Malawi and review of the literature. Health Transition Review, 7(Suppl 2), 75–87
Crampin, A. C., Glynn, J. R., Floyd, S., Malema, S. S., Mwinuka, V. M., Ngwira, B., et al. (2004). Tuberculosis and gender: Exploring the patterns in a case control study in Malawi. International Journal of Tuberculosis and Lung Disease, 8, 194–203
Siriarayapon, P., Yanai, H., Glynn, J. R., Yanpaisarn, S. & Uthaivoravit, W. (2002). The evolving epidemiology of HIV infection and tuberculosis in northern Thailand. Journal of Acquired Immune Deficiency Syndromes, 31, 80–89
Badri, M., Wilson, D. & Wood, R. (2002). Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: A cohort study. The Lancet, 359, 2059–2064
van der Sande, M. A., Schim van der Loeff, M. F., Bennett, R. C., Dowling, M., Aveika, A. A., Togun, T. O., et al. (2004). Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS, 18, 1933–1941
Sonnenberg, P., Glynn, J. R., Fielding, K., Murray, J., Godfrey Fausett, P. & Shearer, S. (2002). How soon after HIV infection does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect D.; 2005: 191: 150–158
Van Cleef, M. R. A. & Chum, H. J. (1995). The proportion of tuberculosis cases in Tanzania attributable to human immunodeficiency virus. International Journal of Epidemiology, 24, 637–642
Chum, H. J., O’Brien, R. J., Chonde, T. M., Graf, P. & Rieder, H. L. (1996). An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991–1993. AIDS, 10, 299–309
Long, R., Scalcini, M., Manfreda, J., Carre, G., Philippe, E., Hershfield, E., et al. (1991). Impact of HIV type I on tuberculosis in rural Haiti. American Review of Respiratory Disease, 143, 69–73
Houston, S., Ray, S., Mahari, M., Neill, P., Legg, W., Latif, A. S., et al. (1994). The association of tuberculosis and HIV infection in Harare, Zimbabwe. Tubercle and Lung Disease, 75, 220–226
Korenromp, E. L., Scano, F., Williams, B. G., Dye, C. & Nunn, P. (2003). Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clinical Infectious Diseases, 37, 101–112
Lambert, M. L., Hasker, E., Van Deun, A., Roberfroid, D., Boelaert, M. & Van der Stuyft, P. (2003). Recurrence in tuberculosis: relapse or reinfection? The Lancet Infectious Diseases, 3, 282–287
Sonnenberg, P., Murray, J., Glynn, J. R., Shearer, S., Kambashi, B. & Godfrey-Faussett, P. (2001). HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: A cohort study in South African mineworkers. The Lancet, 358, 1687–1693
Lienhardt, C. & Rodrigues, L. C. (1997). The estimation of the impact of HIV infection on tuberculosis: tuberculosis risks re-visited? International Journal of Tuberculosis and Lung Disease, 1, 196–204
Odhiambo, J. A., Borgdorff, M. W., Kiambih, F. M., Kibuga, D. K., Kwamanga, D. O., Ng’ang’a L., et al. (1999). Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986–1996. American Journal of Public Health, 89, 1078–1082
Tanzanian- Tuberculin-Survey-Collaboration (2001). Tuberculosis control in the era of the HIV epidemic: risk of tuberculosis infection in Tanzania, 1983–1998. International Journal of Tuberculosis and Lung Disease, 5, 103–112
Corbett, E. L., Charalambos, S., Fielding, K., Clayton, T., Hayes, R. J., De Cock, K. M. & Churchyard, G. J. (2003). Stable incidence rates of tuberculosis (TB) among Human Immunodeficiency Virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB. Journal of Infectious Diseases, 188, 1156–1163
Elliott, A. M., Halwiindi, B., Hayes, R. J., Luo, N., Tembo, G., Machiels, L., et al. (1993). The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. Journal of Tropical Medicine and Hygiene, 96, 1–11
Cauthen, G. M., Dooley, S. W., Onorato, I. M., Ihle, W. W., Burr, J. M., Bigler, W. J., et al. (1996). Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS. American Journal of Epidemiology, 144, 69–77
Elliott, A. M., Hayes, R. J., Halwiindi, B., Luo, N., Tembo, G., Pobee, J. O. M., et al. (1993). The impact of HIV on infectiousness of pulmonary tuberculosis: A community study in Zambia. AIDS, 7, 981–987
Espinal, M. A., Perez, E. N., Baez, J., Henriquez, L., Fernandez, K., Lopez, M., et al. (2000). Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. The Lancet, 355, 275–280
Nunn, P., Mungai, M., Nyamwaya, J., Gicheha, C., Brindle, R. J., Dunn, D. T., et al. (1994). The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tubercle and Lung Disease, 75, 25–32
Klausner, J. D., Ryder, R. W., Baende, E., Lelo, U., Williame, J. C., Ngamboli, K., et al. (1993). Mycobacterium tuberculosis in household contacts of human immunodeficiency virus type 1-seropositive patients with active pulmonary tuberculosis in Kinshasa, Zaire. Journal of Infectious Diseases, 168, 106–111
Cruciani, M., Malena, M., Bosco, O., Gatti, G. & Serpelloni, G. (2001). The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clinical Infectious Diseases, 33, 1922–1930
Girardi, E., Raviglione, M. C., Antonucci, G., Godfrey-Faussett, P. & Ippolito, G. (2000). Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS, 14(Suppl 3), S47–S56
Salaniponi, F. M., Gausi, F., Mphasa, N., Nyirenda, T. E., Kwanjana, J. H. & Harries, A. D. (2003). Decentralisation of treatment for patients with tuberculosis in Malawi: Moving from research to policy and practice. International Journal of Tuberculosis and Lung Disease, 7, S38–S47
Bucher, H. C., Griffith, L. E., Guyatt, G. H., Sudre, P., Naef, M., Sendi, P. & Battegay, M. (1999). Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS, 13, 501–507
Quigley, M. A., Mwinga, A., Hosp, M., Lisse, I., Fuchs, D., Porter, J. D. H. & Godfrey-Faussett, P. (2001). Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS, 15, 215–222
Lugada, E. S., Watera, C., Nakiyingi, J., Elliott, A., Brink, A., Nanyunja, M., et al. (2006). Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda. International Journal of Tuberculosis and Lung Disease, 6, 326–331
Bakari, M., Moshi, A., Aris, E. A., Chale, S., Josiah, R., Magao, P., et al. (2000). Isoniazid prophylaxis for tuberculosis prevention among HIV infected police officers in Dar es Salaam. East African Medical Journal, 77, 494–497
Williams, B. G. & Dye, C. (2003) Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science, 301, 1535–1537
Harries, A. D., Hargreaves, N. J., Chimzizi, R. & Salaniponi, F. M. (2002). Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential. Bulletin of the World Health Organization, 80, 464–469
Harries, A. D., Nyangulu, D. S., Hargreaves, N. J., Kaluwa, O. & Salaniponi, F. M. (2001). Preventing antiretroviral anarchy in sub-Saharan Africa. The Lancet, 358, 410–414
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Glynn, J.R. (2007). The Impact of HIV Infection on Tuberculosis in Africa. In: Caraël, M., Glynn, J.R. (eds) HIV, Resurgent Infections and Population Change in Africa. International Studies in Population, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6174-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6174-5_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6172-1
Online ISBN: 978-1-4020-6174-5
eBook Packages: MedicineMedicine (R0)